- Home
- FLUX vs ATRA Comparison
FLUX vs ATRA Comparison
Compare FLUX & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- ATRA
- Stock Information
- Founded
- FLUX N/A
- ATRA 2012
- Country
- FLUX United States
- ATRA United States
- Employees
- FLUX N/A
- ATRA N/A
- Industry
- FLUX Industrial Machinery/Components
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLUX Miscellaneous
- ATRA Health Care
- Exchange
- FLUX Nasdaq
- ATRA Nasdaq
- Market Cap
- FLUX 51.4M
- ATRA 50.3M
- IPO Year
- FLUX N/A
- ATRA 2014
- Fundamental
- Price
- FLUX $2.32
- ATRA $10.61
- Analyst Decision
- FLUX Strong Buy
- ATRA Hold
- Analyst Count
- FLUX 4
- ATRA 5
- Target Price
- FLUX $9.50
- ATRA $26.88
- AVG Volume (30 Days)
- FLUX 67.9K
- ATRA 143.9K
- Earning Date
- FLUX 11-29-2024
- ATRA 11-12-2024
- Dividend Yield
- FLUX N/A
- ATRA N/A
- EPS Growth
- FLUX N/A
- ATRA N/A
- EPS
- FLUX N/A
- ATRA N/A
- Revenue
- FLUX $63,850,000.00
- ATRA $100,439,000.00
- Revenue This Year
- FLUX N/A
- ATRA $1,190.80
- Revenue Next Year
- FLUX $13.51
- ATRA N/A
- P/E Ratio
- FLUX N/A
- ATRA N/A
- Revenue Growth
- FLUX N/A
- ATRA 2111.34
- 52 Week Low
- FLUX $2.02
- ATRA $6.50
- 52 Week High
- FLUX $5.86
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- FLUX 34.95
- ATRA 51.14
- Support Level
- FLUX $2.02
- ATRA $11.10
- Resistance Level
- FLUX $2.28
- ATRA $14.93
- Average True Range (ATR)
- FLUX 0.22
- ATRA 1.46
- MACD
- FLUX -0.03
- ATRA -0.14
- Stochastic Oscillator
- FLUX 22.99
- ATRA 24.48
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).